Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 38, 2024 - Issue 12
106
Views
1
CrossRef citations to date
0
Altmetric
Rapid Communication

Neutralizing activity of Usnic acid and β-cyclodextrins complex against SARS-CoV-2 spike pseudovirus

, , , &
Pages 2129-2134 | Received 22 Feb 2023, Accepted 03 Jul 2023, Published online: 12 Jul 2023

References

  • Araujo AA, de Melo MG, Rabelo TK, Nunes PS, Santos SL, Serafini MR, Santos MR, Quintans-Junior LJ, Gelain DP. 2015. Review of the biological properties and toxicity of usnic acid. Nat Prod Res. 29(23):2167–2180. doi:10.1080/14786419.2015.1007455.
  • Arima H, Motoyama K, Irie T. 2011. Recent findings on safety profiles of cyclodextrins, cyclodextrin conjugates, and polypseudorotaxanes. In Cyclodextrins in pharmaceutics, cosmetics, and biomedicine: current and future industrial applications, E.Bilensoy editor. p. 91–122. doi:10.1002/9780470926819.ch5.
  • Calcott MJ, Ackerley DF, Knight A, Keyzers RA, Owen JG. 2018. Secondary metabolism in the lichen symbiosis. Chem Soc Rev. 47(5):1730–1760. doi:10.1039/c7cs00431a.
  • Cannella V, Altomare R, Chiaramonte G, Di Bella S, Mira F, Russotto L, Pisano P, Guercio A. 2019. Cytotoxicity evaluation of endodontic pins on L929 cell line. Biomed Res Int. 2019:3469525. doi:10.1155/2019/3469525.
  • Chen S, Zhang Z, Qing T, Ren Z, Yu D, Couch L, Ning B, Mei N, Shi L, Tolleson WH, et al. 2017. Activation of the Nrf2 signaling pathway in usnic acid- induced toxicity in HepG2 cells. Arch Toxicol. 91(3):1293–1307. doi:10.1007/s00204-016-1775-y.
  • Cutone A, Rosa L, Bonaccorsi di Patti MC, Iacovelli F, Conte MP, Ianiro G, Romeo A, Campione E, Bianchi L, Valenti P, et al. 2022. Lactoferrin binding to SARS-CoV-2 spike glycoprotein blocks pseudoviral entry and relieves iron protein dysregulation in several in vitro models. Pharmaceutics. 14(10):2111. doi:10.3390/pharmaceutics14102111.
  • Filimonov AS, Yarovaya OI, Zaykovskaya AV, Rudometova NB, Shcherbakov DN, Chirkova VY, Baev DS, Borisevich SS, Luzina OA, Pyankov OV, et al. 2022. (+)-Usnic acid and its derivatives as inhibitors of a wide spectrum of SARS-CoV-2 viruses. Viruses. 14(10):2154. doi:10.3390/v14102154.
  • Galla R, Ferrari S, Ruga S, Mantuano B, Rosso G, Tonello S, Rosa L, Valenti P, Uberti F. 2023. Effects of usnic acid to prevent infections by creating a protective barrier in an in vitro study. IJMS. 24(4):3695. doi:10.3390/ijms24043695.
  • Guthappa R. 2020. Docking studies of usnic acid and sodium usnate on SARS cov-2 main protease and spike protein RBD. ChemRxiv. Cambridge: Cambridge Open Engage.
  • Harrison AG, Lin T, Wang P. 2020. Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol. 41(12):1100–1115. doi:10.1016/j.it.2020.10.004.
  • Hu Y, Meng X, Zhang F, Xiang Y, Wang J. 2021. The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor. Emerg Microbes Infect. 10(1):317–330. doi:10.1080/22221751.2021.1888660.
  • Ingólfsdóttir K. 2002. Usnic acid. Phytochemistry. 61(7):729–736. doi:10.1016/s0031-9422(02)00383-7.
  • Jin J, Rao Y, Bian X, Zeng A, Yang G. 2013. Solubility of (+)-usnic acid in water, ethanol, acetone, ethyl acetate and n-hexane. J Solution Chem. 42(5):1018–1027. doi:10.1007/s10953-013-0010-1.
  • Kristmundsdóttir T, Jónsdóttir E, Ogmundsdóttir HM, Ingólfsdóttir K. 2005. Solubilization of poorly soluble lichen metabolites for biological testing on cell lines. Eur J Pharm Sci. 24(5):539–543. doi:10.1016/j.ejps.2005.01.011.
  • Lira MC, Siqueira-Moura MP, Rolim-Santos HM, Galetti FC, Simioni AR, Santos NP, Tabosa Do Egito ES, Silva CL, Tedesco AC, Santos-Magalhães NS. 2009. In vitro uptake and antimycobacterial activity of liposomal usnic acid formulation. J Liposome Res. 19(1):49–58. doi:10.1080/08982100802564628.
  • Luzina OA, Salakhutdinov NF. 2018. Usnic acid and its derivatives for pharmaceutical use: a patent review (2000-2017). Expert Opin Ther Pat. 28(6):477–491. doi:10.1080/13543776.2018.1472239.
  • Nikolić V, Stanković M, Nikolić L, Nikolić G, Ilić-Stojanović S, Popsavin M, Zlatković S, Kundaković T. 2013. Inclusion complexes with cyclodextrin and usnic acid. J Incl Phenom Macrocycl Chem. 76(1-2):173–182. doi:10.1007/s10847-012-0187-8.
  • Oh E, Wang W, Park KH, Park C, Cho Y, Lee J, Kang E, Kang H. 2022. (+)-Usnic acid and its salts, inhibitors of SARS-CoV-2, identified by using in silico methods and in vitro assay. Sci Rep. 12(1):13118. doi:10.1038/s41598-022-17506-3.
  • Perry NB, Benn MH, Brennan NJ, Burgess EJ, Ellis G, Galloway DJ, Lorimer SD, Tangney RS. 1999. Antimicrobial, antiviral and cytotoxic activity of New Zealand lichens. Lichenologist. 31(6):627–636. doi:10.1017/S002428299900081X.
  • Rosa L, Cutone A, Conte MP, Campione E, Bianchi L, Valenti P. 2023. An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection. Biometals. 36(3):417–436. doi:10.1007/s10534-022-00427-z.
  • Santos NP, Nascimento SC, Silva JF, Pereira ECG, Silva NH, Honda NK, Santos-Magalhães NS. 2005. Usnic acid-loaded nanocapsules: an evaluation of cytotoxicity. J Drug Del Sci Tech. 15(5):355–361. doi:10.1016/S1773-2247(05)50065-0.
  • Scirpa P, Scambia G, Masciullo V, Battaglia F, Foti E, Lopez R, Villa P, Malecore M, Mancuso S. 1999. A zinc sulphate and usnic acid preparation used as post-surgical adjuvant therapy in genital lesion by human papillomavirus. Minerva Ginecol. 51(6):255–260. 260.
  • Sokolov DN, Zarubaev VV, Shtro AA, Polovinka MP, Luzina OA, Komarova NI, Salakhutdinov NF, Kiselev OI. 2012. Anti-viral activity of (-)/(+) usnic acids and their derivatives against influenza virus A(H1N1) 2009. Bioorg Med Chem Lett. 22(23):7060–7064. doi:10.1016/j.bmcl.2012.09.084.
  • Wang Q, Zhang Y, Wu L, Niu S, Song C, Zhang Z, Lu G, Qiao C, Hu Y, Yuen K-Y, et al. 2020. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell. 181(4):894–904.e9. doi:10.1016/j.cell.2020.03.045.
  • Wang H, Xuan M, Huang C, Wang C. 2022. Advances in research on bioactivity, toxicity, metabolism, and pharmacokinetics of usnic acid in vitro and in vivo. Molecules. 27(21):7469. doi:10.3390/molecules27217469.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.